학술논문

RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma
Document Type
Article
Source
In: Clinical Lung Cancer. (Clinical Lung Cancer, September 2018, 19(5):e811-e814)
Subject
Language
English
ISSN
19380690
15257304